The Wisconsin Alumni Research Foundation, the technology transfer and licensing arm of the UW-Madison, has filed a lawsuit against Xenon Pharmaceuticals Inc., charging it with breach of contract and other violations of its agreement with WARF.
Attorneys for WARF said the suit, filed Wednesday in U.S. District Court in Madison, seeks to ensure that the interests of UW-Madison and its inventors are protected and that WARF receives its contractual share of a $157-million agreement entered into by Xenon, which is in British Columbia, Canada.